Glenn C. Randall to Antiviral Agents
This is a "connection" page, showing publications Glenn C. Randall has written about Antiviral Agents.
Connection Strength
1.690
-
Daclatasvir inhibits hepatitis C virus NS5A motility and hyper-accumulation of phosphoinositides. Virology. 2015 Feb; 476:168-179.
Score: 0.383
-
Hepatitis C virus replication compartment formation: mechanism and drug target. Gastroenterology. 2014 May; 146(5):1164-7.
Score: 0.364
-
Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection. Gastroenterology. 2006 Nov; 131(5):1584-91.
Score: 0.215
-
Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses. Sci Adv. 2022 Feb 25; 8(8):eabi6110.
Score: 0.157
-
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2. Science. 2021 08 20; 373(6557):931-936.
Score: 0.151
-
Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2. Commun Biol. 2021 02 09; 4(1):193.
Score: 0.147
-
Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects. J Clin Invest. 2017 Apr 03; 127(4):1338-1352.
Score: 0.111
-
Flavivirus modulation of cellular metabolism. Curr Opin Virol. 2016 08; 19:7-10.
Score: 0.106
-
Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors. Nat Commun. 2021 02 02; 12(1):743.
Score: 0.037
-
A summary of the 18th International Symposium on Hepatitis C Virus and Related Viruses. Gastroenterology. 2012 Jan; 142(1):e1-5.
Score: 0.019